rs766132877
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_024753.5(TTC21B):c.2758-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000232 in 1,592,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_024753.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 12Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- asphyxiating thoracic dystrophy 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Jeune syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TTC21B | NM_024753.5 | c.2758-2A>G | splice_acceptor_variant, intron_variant | Intron 20 of 28 | ENST00000243344.8 | NP_079029.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TTC21B | ENST00000243344.8 | c.2758-2A>G | splice_acceptor_variant, intron_variant | Intron 20 of 28 | 1 | NM_024753.5 | ENSP00000243344.7 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151828Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251206 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000229 AC: 33AN: 1440652Hom.: 0 Cov.: 28 AF XY: 0.0000223 AC XY: 16AN XY: 718194 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151828Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74094 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Asphyxiating thoracic dystrophy 4;C3151186:Nephronophthisis 12 Pathogenic:1
- -
Jeune thoracic dystrophy;C0687120:Nephronophthisis Pathogenic:1
This sequence change affects an acceptor splice site in intron 20 of the TTC21B gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TTC21B are known to be pathogenic (PMID: 18327258, 21068128, 21258341, 23559409, 24876116, 25492405, 27491411, 29068549). This variant is present in population databases (rs766132877, gnomAD 0.005%). Disruption of this splice site has been observed in individual(s) with nephronophthisis (PMID: 21258341). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 30937). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Nephronophthisis 12 Pathogenic:1
- -
Infantile nephronophthisis Pathogenic:1
This variant was identified in composite heterozygosity with another variant in the same gene in a female patient with nephronophtisis, retinopathy and suspected ciliopathy -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at